Virus Induced Thrombosis Alliance (VITAL) is led by Beth Garvy, PhD and Wally Whiteheart, PhD. Thrombosis, the formation of clots in blood vessels, lies at the root of the causes of many cardiovascular disease deaths such as strokes, heart attacks, and deep vein thrombosis (DVT).
Infectious disease can increase the chance of this coagulation dysfunction, and some viral infections, including HIV1+/AIDS, double the risk of occlusive cardiovascular disease. VITAL is investigating why infections cause an increased risk of cardiovascular disease. The combination of cardiology and virology is critical, especially now, as the effect of COVID-19 on clotting becomes clear. VITAL’s initial focus on the thrombotic risks associated with HIV1+/AIDS has grown into a collaboration with the Bluegrass Care Clinic to examine coagulation dysfunction in COVID-19 patients. Follow updates on VITAL here.